List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Viral Detection Revenue in Viral Detection Business (2017-2022) & (US$ Million) Introduction
1.2 Global Viral Detection Outlook 2017 VS 2022 VS 2028
1.2.1 Global Viral Detection Market Size for the Year 2017-2028
1.2.2 Global Viral Detection Market Size for the Year 2017-2028
1.3 Viral Detection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Viral Detection in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Viral Detection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Viral Detection Market Dynamics
1.4.1 Viral Detection Industry Trends
1.4.2 Viral Detection Market Drivers
1.4.3 Viral Detection Market Challenges
1.4.4 Viral Detection Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Viral Detection by Type
2.1 Viral Detection Market Segment by Type
2.1.1 Plaque Assays
2.1.2 PCR
2.1.3 ELISA
2.1.4 Others
2.2 Global Viral Detection Market Size by Type (2017, 2022 & 2028)
2.3 Global Viral Detection Market Size by Type (2017-2028)
2.4 United States Viral Detection Market Size by Type (2017, 2022 & 2028)
2.5 United States Viral Detection Market Size by Type (2017-2028)
3 Viral Detection by Application
3.1 Viral Detection Market Segment by Application
3.1.1 Blood & Blood Products
3.1.2 Cellular & Gene Therapy Products
3.1.3 Stem Cell Products
3.1.4 Tissue & Tissue Products
3.1.5 Vaccines and Therapeutics
3.2 Global Viral Detection Market Size by Application (2017, 2022 & 2028)
3.3 Global Viral Detection Market Size by Application (2017-2028)
3.4 United States Viral Detection Market Size by Application (2017, 2022 & 2028)
3.5 United States Viral Detection Market Size by Application (2017-2028)
4 Global Viral Detection Competitor Landscape by Company
4.1 Global Viral Detection Market Size by Company
4.1.1 Top Global Viral Detection Companies Ranked by Revenue (2021)
4.1.2 Global Viral Detection Revenue by Player (2017-2022)
4.2 Global Viral Detection Concentration Ratio (CR)
4.2.1 Viral Detection Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Viral Detection in 2021
4.2.3 Global Viral Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Viral Detection Headquarters, Revenue in Viral Detection Business (2017-2022) & (US$ Million) Type
4.3.1 Global Viral Detection Headquarters and Area Served
4.3.2 Global Viral Detection Companies Revenue in Viral Detection Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Viral Detection Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Viral Detection Market Size by Company
4.5.1 Top Viral Detection Players in United States, Ranked by Revenue (2021)
4.5.2 United States Viral Detection Revenue by Players (2020, 2021 & 2022)
5 Global Viral Detection Market Size by Region
5.1 Global Viral Detection Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Viral Detection Market Size by Region (2017-2028)
5.2.1 Global Viral Detection Market Size by Region: 2017-2022
5.2.2 Global Viral Detection Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Viral Detection Market Size YoY Growth 2017-2028
6.1.2 North America Viral Detection Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Viral Detection Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Viral Detection Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Viral Detection Market Size YoY Growth 2017-2028
6.3.2 Europe Viral Detection Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Viral Detection Market Size YoY Growth 2017-2028
6.4.2 Latin America Viral Detection Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Viral Detection Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Viral Detection Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Avance Biosciences Inc (US)
7.1.1 Avance Biosciences Inc (US) Company Details
7.1.2 Avance Biosciences Inc (US) Business Overview
7.1.3 Avance Biosciences Inc (US) Viral Detection Introduction
7.1.4 Avance Biosciences Inc (US) Revenue in Viral Detection Business (2017-2022)
7.1.5 Avance Biosciences Inc (US) Recent Development
7.2 BSL BIOSERVICE (Germany)
7.2.1 BSL BIOSERVICE (Germany) Company Details
7.2.2 BSL BIOSERVICE (Germany) Business Overview
7.2.3 BSL BIOSERVICE (Germany) Viral Detection Introduction
7.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2017-2022)
7.2.5 BSL BIOSERVICE (Germany) Recent Development
7.3 Clean Cells (France)
7.3.1 Clean Cells (France) Company Details
7.3.2 Clean Cells (France) Business Overview
7.3.3 Clean Cells (France) Viral Detection Introduction
7.3.4 Clean Cells (France) Revenue in Viral Detection Business (2017-2022)
7.3.5 Clean Cells (France) Recent Development
7.4 Charles River Laboratories International, Inc (US)
7.4.1 Charles River Laboratories International, Inc (US) Company Details
7.4.2 Charles River Laboratories International, Inc (US) Business Overview
7.4.3 Charles River Laboratories International, Inc (US) Viral Detection Introduction
7.4.4 Charles River Laboratories International, Inc (US) Revenue in Viral Detection Business (2017-2022)
7.4.5 Charles River Laboratories International, Inc (US) Recent Development
7.5 Lonza Group (Switzerland)
7.5.1 Lonza Group (Switzerland) Company Details
7.5.2 Lonza Group (Switzerland) Business Overview
7.5.3 Lonza Group (Switzerland) Viral Detection Introduction
7.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2017-2022)
7.5.5 Lonza Group (Switzerland) Recent Development
7.6 Merck KGaA (Germany)
7.6.1 Merck KGaA (Germany) Company Details
7.6.2 Merck KGaA (Germany) Business Overview
7.6.3 Merck KGaA (Germany) Viral Detection Introduction
7.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2017-2022)
7.6.5 Merck KGaA (Germany) Recent Development
7.7 Sigma-Aldrich Corporation (US)
7.7.1 Sigma-Aldrich Corporation (US) Company Details
7.7.2 Sigma-Aldrich Corporation (US) Business Overview
7.7.3 Sigma-Aldrich Corporation (US) Viral Detection Introduction
7.7.4 Sigma-Aldrich Corporation (US) Revenue in Viral Detection Business (2017-2022)
7.7.5 Sigma-Aldrich Corporation (US) Recent Development
7.8 SGS S.A. (Switzerland)
7.8.1 SGS S.A. (Switzerland) Company Details
7.8.2 SGS S.A. (Switzerland) Business Overview
7.8.3 SGS S.A. (Switzerland) Viral Detection Introduction
7.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2017-2022)
7.8.5 SGS S.A. (Switzerland) Recent Development
7.9 Texcell, Inc. (France)
7.9.1 Texcell, Inc. (France) Company Details
7.9.2 Texcell, Inc. (France) Business Overview
7.9.3 Texcell, Inc. (France) Viral Detection Introduction
7.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2017-2022)
7.9.5 Texcell, Inc. (France) Recent Development
7.10 WuXi PharmaTech (Cayman) Inc. (China)
7.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Details
7.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
7.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Introduction
7.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2017-2022)
7.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
